(Stroke. 2001;32:1028.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurosurgery (M.A.Y., M.M., G.H.S., D.M.K., G.K.S.), Neurology (M.A.Y., R.M.S.), and Biological Sciences (T.J.M., J.R.M., D.Y.H., R.M.S.) and Stanford Stroke Center (M.A.Y., M.M., G.H.S., T.J.M., D.M.K., J.R.M., D.Y.H., R.M.S., G.K.S.), Stanford University (Calif).
Correspondence to Midori A. Yenari, MD, Departments of Neurosurgery, Neurology, and Neurological Sciences, Stanford University School of Medicine, 1201 Welch Rd, MSLS Bldg B P304, Stanford, CA 94305-5487. E-mail yenari{at}stanford.edu
Background and PurposeIncreased intracellular calcium accumulation is known to potentiate ischemic injury. Whether endogenous calcium-binding proteins can attenuate this injury has not been clearly established, and existing data are conflicting. Calbindin D28K (CaBP) is one such intracellular calcium buffer. We investigated whether CaBP overexpression is neuroprotective against transient focal cerebral ischemia.
MethodsBipromoter, replication-incompetent herpes simplex virus vectors that encoded the genes for cabp and, as a reporter gene, lacZ were used. Sprague-Dawley rats received bilateral striatal injections of viral vector 12 to 15 hours before ischemia onset. With the use of an intraluminal occluding suture, animals were subjected to 1 hour of middle cerebral artery occlusion followed by 47 hours of reperfusion. Brains were harvested and stained with X-gal (to visualize ß-galactosidase, the gene product of lacZ). The number of remaining virally transfected, X-galstained neurons in both the ischemic and contralateral striata were counted and expressed as the percentage of surviving neurons in the ischemic striatum relative to the contralateral nonischemic striatum.
ResultsStriatal neuron survivorship among cabp-injected animals was 53.5±4.1% (n=10) versus 26.8±5.4% among those receiving lacZ (n=9) (mean±SEM; P<0.001).
ConclusionsWe conclude that viral vectormediated overexpression of CaBP leads to neuroprotection in this model of central nervous system injury. This is the first demonstration that CaBP overexpression protects neurons in a focal stroke model.
Key Words: calcium calcium-binding protein cerebral ischemia, focal cerebral ischemia, transient gene therapy
This article has been cited by other articles:
![]() |
M. Palczewska, G. Batta, P. Groves, S. Linse, and J. Kuznicki Characterization of calretinin I-II as an EF-hand, Ca2+, H+-sensing domain Protein Sci., July 1, 2005; 14(7): 1879 - 1887. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, M. A. Yenari, R. M. Sapolsky, and G. K. Steinberg Mild Postischemic Hypothermia Prolongs the Time Window for Gene Therapy by Inhibiting Cytochrome c Release Stroke, February 1, 2004; 35(2): 572 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoehn, M.A. Yenari, R.M. Sapolsky, and G.K. Steinberg Glutathione Peroxidase Overexpression Inhibits Cytochrome c Release and Proapoptotic Mediators to Protect Neurons From Experimental Stroke Stroke, October 1, 2003; 34(10): 2489 - 2494. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |